clorazepate dipotassium has been researched along with cocaine in 3 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (cocaine) | Trials (cocaine) | Recent Studies (post-2010) (cocaine) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 32,461 | 1,096 | 9,400 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | cocaine (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.338 | |
| Fatty acid-binding protein, heart | Homo sapiens (human) | 0.367 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0855 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0855 | |
| D | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2861 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.4321 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0855 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.5442 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.8885 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.3796 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.541 | |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | 0.2 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.05 | |
| Transporter | Rattus norvegicus (Norway rat) | 3.2277 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balster, RL; Woolverton, WL | 1 |
| Capasso, A; Cavallo, F; Ding, Z; Raffa, RB; Rawls, SM | 1 |
| Bires, K; Kim, E; Nayak, S; Rawls, SM; Roberts, A; Tallarida, CS; Wu, M | 1 |
3 other study(ies) available for clorazepate dipotassium and cocaine
| Article | Year |
|---|---|
Intravenous buspirone self-administration in rhesus monkeys.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Chlordiazepoxide; Clorazepate Dipotassium; Cocaine; Conditioning, Operant; Injections, Intravenous; Macaca mulatta; Pyrimidines; Reinforcement, Psychology; Self Administration; Sodium Chloride | 1982 |
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anti-Bacterial Agents; Ceftriaxone; Clorazepate Dipotassium; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Methamphetamine; Models, Animal; Motor Activity; Planarians; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2008 |
Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Clorazepate Dipotassium; Cocaine; Darkness; Dose-Response Relationship, Drug; Ethanol; Light; Planarians; Substance Withdrawal Syndrome; Time Factors | 2016 |